| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |